Causes, clinical features and outcomes of drug-induced liver injury in hospitalized patients in a Chinese tertiary care hospital

SpringerPlus

Volumn 4, Issue 1, 2015, Pages 1-8

  Ou, Pengcheng ^a   Chen, Yi ^b   Li, Baozhen ^a   Zhang, Min ^a   Liu, Xingyu ^a   Li, Fangfang ^a   Li, Yi ^a   Chen, Chengwei ^c   Mao, Yimin ^d   Chen, Jun ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Normin Health Changsha Representative Office   (China)

^c Shanghai Liver Disease Research Center of Nanjing Military Region of PLA   (China)

^d SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Chinese herbal medicine; Drug induced liver injury; Incidence; Prognosis

Indexed keywords

EID: 84951023755     PISSN: None     EISSN: 21931801     Source Type: Journal    
DOI: 10.1186/s40064-015-1600-8     Document Type: Review

References (21)

1. Andrade RJ, Lucena MI, Fernandez MC, Pelaez G, Pachkoria K, Garcia-Ruiz E et al (2005) Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 129:512–521
2. Björnsson E, Olsson R (2005) Outcome and prognostic markers in severe drug-induced liver disease. Hepatology 42(2):481–489
3. Björnsson ES, Bergmann OM, Björnsson HK, Kvaran RB, Olafsson S (2013) Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology 144(7):1419–1425
4. Chalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, Davern T, Serrano J et al (2008) Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 135:1924–1934
5. Chalasani NP, Hayashi PH, Bonkovsky HL, Navarro VJ, Lee WM, Fontana RJ (2014) Practice Parameters Committee of the American College of Gastroenterology. ACG clinical guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol 109(7):950–966
6. Chalasani N, Bonkovsky HL, Fontana R, Lee W, Stolz A, Talwalkar J et al (2015) United States drug induced liver injury network. features and outcomes of 889 patients with drug-induced liver injury: the DILIN prospective study. Gastroenterology 148(7):1340–1352
7. Devarbhavi H, Dierkhising R, Kremers WK, Sandeep MS, Karanth D, Adarsh CK (2010) Single-center experience with drug induced liver injury from India: causes, outcome, prognosis, and predictors of mortality. Am J Gastroenterol 105:2396–2404
8. Devarbhavi H, Singh R, Patil M et al (2013) Outcome and determinants of mortality in 269 patients with combination anti-tuberculosis drug-induced liver injury. J Gastroenterol Hepatol 28(1):161–167
9. Jeong R, Lee YS, Sohn C, Jeon J, Ahn S, Lim KS (2015) Model for end-stage liver disease score as a predictor of short-term outcome in patients with drug-induced liver injury. Scand J Gastroenterol 50(4):439–446
10. Lai RT, Wang H, Gui HL, Ye MZ, Dai WJ, Xiang XG et al (2012) Clinical and pathological features in 138 cases of drug-induced liver injury. Zhonghua Gan Zang Bing Za Zhi 20(3):185–189. doi:10.3760/cma.j.issn.1007-3418.2012.03.009Article in Chinese
11. Larrey D, Pageaux GP (2005) Drug-induced acute liver failure. Eur J Gastroenterol Hepatol 17(2):141–143
12. Lee WM (2003) Acute liver failure in the United States. Semin Liver Dis 23(3):217–226
13. Martin P, DiMartini A, Feng S, Brown R Jr, Fallon M (2014) Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology 59(3):1144–1165
14. Ostapowicz G, Fontana RJ, Schiødt FV, Larson A, Davern TJ, Han SH et al (2002) Results of a preospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 137(12):947–954
15. Polson J, Lee WM (2005) American Association for the Study of Liver Disease. AASLD position paper: the management of acute liver failure. Hepatology 41(5):1179–1197
16. Said A, Williams J, Holden J, Remington P, Gangnon R, Musat A et al (2004) Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 40(6):897–903
17. Shu CC, Lee CH, Lee MC, Wang JY, Yu CJ, Lee LN (2013) Hepatotoxicity due to first-line anti-tuberculosis drugs: a five-year experience in a Taiwan medical centre. Int J Tuberc Lung Dis 17(7):934–939. doi:10.5588/ijtld.12.0782
18. Suk KT, Kim DJ, Kim CH, Park SH, Yoon JH, Kim YS et al (2012) A prospective nationwide study of drug induced liver injury in Korea. Am J Gastroenterol 107:1380–1387
19. Temple R (2006) Hy’s law: predicting serious hepatotoxicity. Pharmacoepidemiol Drug Saf 15:241–243
20. Wai CT (2006) Presentation of drug-induced liver injury in Singapore. Singapore Med J 47:116–120
21. Zhou Y, Yang L, Liao Z, He X, Zhou Y, Guo H (2013) Epidemiology of drug-induced liver injury in China: a systematic analysis of the Chinese literature including 21,789 patients. Eur J Gastroenterol Hepatol 25(7):825–829